Quadra Logic Technologies Inc.
13Patents
0Active
13Granted
35Portfolio score
Filing activity: Oct 16, 1987 → Nov 8, 1995
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5798349A | Use of green porphyrins to treat neovasculature in the eye | Human Necessities | 116 | Expired |
| US5422362A | Method to inhibit restenosis | Human Necessities | 98 | Expired |
| US5360734A | Method for inactivating pathogens in erythrocytes using photoactive compounds and plasma protein reduction | Human Necessities | 85 | Expired |
| US5053423A | Compositions for photodynamic therapy | Human Necessities | 57 | Expired |
| US4874691A | Membrane-supported immunoassays | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5868695A | Systems and methods for eradicating contaminants using photoactive materials in fluids like blood using discrete sources of radiation | Performing Operations; Transporting | 36 | Expired |
| US5484803A | Transcutaneous in vivo activation of photosensitive agents in blood | Human Necessities | 34 | Expired |
| US5238940A | Compositions for photodynamic therapy | Human Necessities | 31 | Expired |
| US5807881A | Method for selectively reducing activated leukocyte cell population | Human Necessities | 21 | Expired |
| US5736563A | Transcutaneous in vivo activation of photosensitive agents in blood | Human Necessities | 20 | Expired |
| US5776966A | Selective cell inactivation in blood | Human Necessities | 17 | Expired |
| US5789433A | Green porphyrins as immunomodulators | Chemistry; Metallurgy | 10 | Expired |
| US5059619A | Stable freeze-dried polyhematoporphyrin ether/ester | Human Necessities | 8 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.